Glaxosmithkline Pharmaceuticals | Sustainability Performance
Indian subsidiary of GSK, focusing on pharmaceutical products and healthcare solutions.
1924
India
1,001 - 5,000 employees
Pharmaceuticals
$100M - 500M in revenue
$100M - 500M in profitability
Sustainability Ranking & Industry Benchmark
#6397
Overall#98
in India#135
in PharmaceuticalsSustainability Maturity
Sustainability Intent
Overview
Governance
TargetsESG scores and exclusionsFinancial Data
Business performanceCapital & innovationAnalyst projections
Market cap
Revenue
R&D intensity
Controversy level
Powered by illuminem
Market cap
Revenue
EBITDA
Operating margin
Revenue & EBITDA
$438.6MFY2026 revenue
Total Annual
Revenue & EBITDA
($ B)
Annual revenue
EBITDA
3 year change
Margin trends
Margin as % of revenue
Gross margin
Operating margin
Net margin
Powered by illuminem
Free cashflow
Capex
Debt/equity ratio
R&D intensity
0.1%FY2026
R&D as % of revenue
R&D as % of revenue
Industry benchmark
Powered by illuminem
Return on invested capital
45.0%FY2026
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Analyst revenue estimates & actuals
Analyst consensus vs actuals
($ B)
Actual revenue
Consensus estimates
Estimate only
0.4
▲ 2.3%
0.4
▼ 0.9%
0.4
▼ 1.6%
47.2
2028Powered by illuminem
Environmental policy coverage
Carbon reduction policy
Not available
Human rights policy
Available
Recycling policy
Available
Workplace health & safety policy
Available
22%
Independent Directors
5 out of 23 incl. management
Overall score
63
Environment
76
Social
79
Governance
35
Exclusion screening
Adult content
Not available
Alcoholic
Not available
Animal testing
Available
Firearms
Not available
Tobacco
Not available
Gambling
Not available
Nuclear
Not available
